These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9610663)

  • 1. CMF + radiotherapy in the primary treatment of operable breast cancer: preliminary results of a phase II pilot study.
    Bellantone R; Lombardi CP; Cefaro GA; Nardone L; Rossi S; Minelli S; Raffaelli M; Crucitti F
    J Surg Oncol; 1998 May; 68(1):48-50. PubMed ID: 9610663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : long-term results from the University of Texas M. D. Anderson Cancer Center Study ID97-099.
    Alvarez RH; Booser DJ; Cristofanilli M; Sahin AA; Strom EA; Guerra L; Kau SW; Gonzalez-Angulo AM; Hortobagyi GN; Valero V
    Cancer; 2010 Mar; 116(5):1210-7. PubMed ID: 20082452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.
    Overgaard M; Hansen PS; Overgaard J; Rose C; Andersson M; Bach F; Kjaer M; Gadeberg CC; Mouridsen HT; Jensen MB; Zedeler K
    N Engl J Med; 1997 Oct; 337(14):949-55. PubMed ID: 9395428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm.
    Calais G; Berger C; Descamps P; Chapet S; Reynaud-Bougnoux A; Body G; Bougnoux P; Lansac J; Le Floch O
    Cancer; 1994 Aug; 74(4):1283-8. PubMed ID: 8055449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes.
    Shapiro CL; Gelman RS; Hayes DF; Osteen R; Obando A; Canellos GP; Frei E; Henderson IC
    J Natl Cancer Inst; 1993 May; 85(10):812-7. PubMed ID: 8487326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic and antiproliferative activity of the CMF regimen administered in association with tamoxifen as primary chemotherapy in breast cancer patients.
    Bottini A; Berruti A; Bersiga A; Brunelli A; Brizzi MP; Di Marco B; Cirillo F; Tampellini M; Bolsi G; Aguggini S; Betri E; Filippini L; Bertoli A; Alquati P; Dogliotti L
    Int J Oncol; 1998 Aug; 13(2):385-90. PubMed ID: 9664137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of neoadjuvant CMF to avoid mastectomy.
    George ML; Hale PC; Gumpert JR; Hogbin BM; Deutsch GP; Yelland A
    Eur J Surg Oncol; 1999 Feb; 25(1):50-3. PubMed ID: 10188855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodality treatment of noninflammatory stage IIIb breast cancer.
    Gliński B; Pawlicki M; Reinfuss M; Skołyszewski J; Brandys A; Krzemieniecki K; Zuchowska B; Mitus J; Stelmach A; Walasek T
    J Surg Oncol; 1997 Nov; 66(3):179-85. PubMed ID: 9369963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined chemotherapy and radiotherapy for patients with breast cancer and extensive nodal involvement.
    Ung O; Langlands AO; Barraclough B; Boyages J
    J Clin Oncol; 1995 Feb; 13(2):435-43. PubMed ID: 7844606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer. International Breast Cancer Study Group.
    Wallgren A; Bernier J; Gelber RD; Goldhirsch A; Roncadin M; Joseph D; Castiglione-Gertsch M
    Int J Radiat Oncol Biol Phys; 1996 Jul; 35(4):649-59. PubMed ID: 8690630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma.
    Cocconi G; Di Blasio B; Boni C; Bisagni G; Ceci G; Rondini E; Bella M; Leonardi F; Savoldi L; Camisa R; Bruzzi P
    Cancer; 2002 Jul; 95(2):228-35. PubMed ID: 12124820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of adjuvant chemotherapy in male breast cancer.
    Patel HZ; Buzdar AU; Hortobagyi GN
    Cancer; 1989 Oct; 64(8):1583-5. PubMed ID: 2676137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy.
    Thomas F; Arriagada R; Spielmann M; Mouriesse H; Le Chevalier T; Fontaine F; Tursz T
    Cancer; 1995 Dec; 76(11):2286-90. PubMed ID: 8635033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more.
    Bonadonna G; Veronesi U; Brambilla C; Ferrari L; Luini A; Greco M; Bartoli C; Coopmans de Yoldi G; Zucali R; Rilke F
    J Natl Cancer Inst; 1990 Oct; 82(19):1539-45. PubMed ID: 2402015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in premonopausal patients with node-positive breast cancer: indirect comparison of dose and schedule in DBCG trials 77, 82, and 89.
    Ejlertsen B; Mouridsen HT; Jensen MB
    Acta Oncol; 2008; 47(4):662-71. PubMed ID: 18465334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy with cyclophosphamide, mitoxantrone, and 5-fluorouracil in locally advanced breast cancer.
    Erol K; Baltali E; Altundag K; Guler N; Ozisik Y; Onat DA; Sayek I; Cengiz M; Atahan L; Tekuzman G
    Onkologie; 2005 Feb; 28(2):81-5. PubMed ID: 15662111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
    Fowble B; Hanlon AL; Patchefsky A; Freedman G; Hoffman JP; Sigurdson ER; Goldstein LJ
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):105-15. PubMed ID: 9747827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy in operable breast cancer: cyclophosphamide, methotrexate, and fluorouracil versus chlorambucil, methotrexate, and fluorouracil--11-year results of Swiss Group for Clinical Cancer Research trial SAKK 27/82.
    Senn HJ; Maibach R; Castiglione M; Jungi WF; Cavalli F; Leyvraz S; Obrecht JP; Schildknecht O; Siegenthaler P
    J Clin Oncol; 1997 Jul; 15(7):2502-9. PubMed ID: 9215818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer.
    Semiglazov VF; Topuzov EE; Bavli JL; Moiseyenko VM; Ivanova OA; Seleznev IK; Orlov AA; Barash NY; Golubeva OM; Chepic OF
    Ann Oncol; 1994 Sep; 5(7):591-5. PubMed ID: 7993833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative surgery in breast cancer.
    Veronesi U; Costa A
    Ann N Y Acad Sci; 1993 Nov; 698():212-8. PubMed ID: 8279760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.